Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ANAB AnaptysBio, Inc. Common Stock
$50.44 -0.12% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ANAB stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

AnaptysBio, Inc. Common Stock (ANAB)

Loading

Key Stats

Market cap. 1.5B
Enterprise value 1.6B
Trailing PE -109.65217391304
Forward PE 10.935042
PEG Ratio -2.5063354037267
Enterprise to EBITDA 24.183
Enterprise to revenue 14.98
Price to book MRQ 139.41011
Price to sales TTM 13.985568

Financials

Fiscal Year Ends 2026-06-30
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 106.1M
EBITDA 69.2M
Diluted EPS TTM -0.96
Total Cash (MRQ) 164.1M
Current ratio (MRQ) 5.613
Operating Cash Flow (TTM) -105118000

ANAB trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ANAB News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.